A Prospective Cohort Post Market Registry Evaluating Outcomes of Bridge-Enhanced ACL Restoration (BEAR®) | MicrobiomeTrials← Back to trialsNCT05398341
A Prospective Cohort Post Market Registry Evaluating Outcomes of Bridge-Enhanced ACL Restoration (BEAR®)
RecruitingOBSERVATIONAL
Trial Details
Start: 2023-02-28Est. Completion: 2026-10-30
Enrollment target: 300 participants Locations- Stanford, Redwood City, California, United States
- Steamboat Orthopaedic and Spine Institute, Steamboat Springs, Colorado, United States
- Advent Health, Orlando, Florida, United States
- Virtua Health, Marlton, New Jersey, United States
- Hospital for Special Surgery, New York, New York, United States
- Victory Sports Medicine, Skaneateles, New York, United States
- Duke University, Durham, North Carolina, United States
- Oregon Health & Science University (OHSU), Portland, Oregon, United States
Other microbiome trials you might be interested in
ACL InjuryMeniscus TearPost-traumatic Osteoarthritis
This is a multicenter randomized, placebo-controlled trial to assess whether a 6-month course of oral montelukast after …
Lexington, United StatesEst. completion Jun 2027
Orthopedic DisorderAnterior Cruciate Ligament Injuries
The choice of autograft for ACL reconstruction continues to be debated. To date, there has only be one completed randomi…
Birmingham, United StatesEst. completion Jun 30, 2030